Tilia Fiduciary Partners Inc. Acquires 81 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Tilia Fiduciary Partners Inc. raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.7% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 3,108 shares of the healthcare conglomerate’s stock after purchasing an additional 81 shares during the quarter. UnitedHealth Group comprises about 1.5% of Tilia Fiduciary Partners Inc.’s investment portfolio, making the stock its 25th biggest holding. Tilia Fiduciary Partners Inc.’s holdings in UnitedHealth Group were worth $1,636,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. Axiom Financial Strategies LLC purchased a new stake in shares of UnitedHealth Group in the first quarter valued at $210,000. McGowan Group Asset Management Inc. lifted its stake in UnitedHealth Group by 8.9% in the first quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock worth $379,000 after purchasing an additional 61 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its holdings in UnitedHealth Group by 31.8% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock valued at $127,592,000 after acquiring an additional 60,300 shares during the period. MAS Advisors LLC increased its stake in UnitedHealth Group by 10.8% in the 1st quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock worth $241,000 after buying an additional 45 shares during the period. Finally, First Western Trust Bank bought a new stake in shares of UnitedHealth Group during the first quarter valued at approximately $875,000. 85.69% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Down 0.3 %

Shares of NYSE UNH traded down $1.68 during trading on Friday, hitting $490.01. 2,846,975 shares of the company traded hands, compared to its average volume of 4,168,188. The firm has a market capitalization of $451.75 billion, a P/E ratio of 20.60, a P/E/G ratio of 1.35 and a beta of 0.54. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62. The company has a 50-day moving average price of $505.61 and a 200-day moving average price of $518.05. UnitedHealth Group Incorporated has a 1 year low of $445.68 and a 1 year high of $554.70.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.98 by $0.18. The firm had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm’s quarterly revenue was up 14.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $5.34 EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 27.79 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.53%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 31.54%.

Analysts Set New Price Targets

A number of research firms recently weighed in on UNH. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $596.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 29th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research report on Friday, January 19th. Piper Sandler reduced their price target on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 17th. HSBC reiterated a “reduce” rating and issued a $480.00 price objective (down previously from $550.00) on shares of UnitedHealth Group in a research note on Monday, December 18th. Finally, Truist Financial restated a “buy” rating and set a $610.00 price objective on shares of UnitedHealth Group in a research report on Thursday, November 30th. One research analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $579.33.

Insiders Place Their Bets

In related news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.